NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Clinical trial NCT05661201 · RECRUITING

Trial details

NCT number: NCT05661201
Sponsor: Georgetown University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor KRAS Mutation-Related Tumors

Start date: 2023-04-12
Primary completion: 2027-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.